Targeting of Erb antigens

Details for Australian Patent Application No. 2004292933 (hide)

Owner Glycorex Transplantation AB

Inventors Nilsson, Rune; Sandberg, Bengt E. B.

Agent Davies Collison Cave

Pub. Number AU-B-2004292933

PCT Pub. Number WO2005/051424

Priority 0303229-9 28.11.03 SE; 60/525,703 28.11.03 US

Filing date 26 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 6 January 2011

International Classifications

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051424 Priority application(s): WO2005/051424

23 December 2010 Alteration of Name

  The name of the applicant has been altered to Glycorex Transplantation AB 2005

23 December 2010 Assignment before Grant

  Mitra Medical AB The application has been assigned to Glycorex Transplatation AB 2005

6 January 2011 Application Accepted

  Published as AU-B-2004292933

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292936-Methods of fabricating brachytherapy implant seeds

2004292928-Iron powder, use as additive for foods, food additive and method of making iron powder.